Ligustrazine ameliorates acute kidney injury through downregulation of NOD2-mediated inflammation

Ligustrazine has been used to alleviate clinical acute kidney injury (AKI); however, the underlying molecular mechanisms are poorly understood. In order to further elucidate the molecular mechanism underlying its occurrence, the role of nucleotide-binding oligomerization domain-containing 2 (NOD2) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Guosheng, Xin, Rui, Yuan, Wendan, Zhang, Lixia, Meng, Xianghui, Sun, Wangnan, Han, Huirong, Hou, Yun, Wang, Lin, Du, Pengchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015130/
https://www.ncbi.nlm.nih.gov/pubmed/31985025
http://dx.doi.org/10.3892/ijmm.2020.4464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015130/
https://www.ncbi.nlm.nih.gov/pubmed/31985025
http://dx.doi.org/10.3892/ijmm.2020.4464

Ejemplares similares